ConductScience.org, home

Paper23908470

Biomarkers for prediction of venous thromboembolism in cancer.

Pabinger I and 2 others. Blood, 2013. Cited by 202 papers, by iCite.

Cite this record

ConductScience Library. Biomarkers for prediction of venous thromboembolism in cancer. Papers, record 23908470. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23908470

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Biomarkers for prediction of venous thromboembolism in cancer.
PubMed
Journal
Blood
PubMed
Year
2013
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
202
iCite
Relative citation ratio, by iCite
6.92
iCite
Revised in PubMed
2022-04-09
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pabinger IIngrid
2Thaler JJohannes
3Ay CCihan

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
Venous ThromboembolismMajor topic
Biomarkers
Blood Coagulation
Humans
Prognosis

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT03646409Venous Thromboembolism and Bleeding Risk in Patients With Esophageal CancerBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by120

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 202 citations.

PMIDTitleJournalYearIn PapersSource
42780610Elevated D-dimer levels in high-risk multiple myeloma patients: a systematic review and meta-analysis.Front Oncol2026https://conductscience.org/library/papers/42780610PubMed
42645093Systemic Immune-Inflammation Index, Thrombotic Status, and Mortality in Patients with Cancer: A Matched Cohort Study.Diseases2026https://conductscience.org/library/papers/42645093PubMed
42355911Persistent Hypercoagulability After Radical Prostatectomy: Biomarker Dynamics and Implications for Individualized Thromboprophylaxis.J Clin Med2026https://conductscience.org/library/papers/42355911PubMed
42353272An Immunothrombotic Extracellular Vesicle mRNA Profile Associated with Thrombosis in Lung Adenocarcinoma.Int J Mol Sci2026https://conductscience.org/library/papers/42353272PubMed
42149309External validation of established clinical risk scores for cancer-associated venous thromboembolism in a Brazilian registry.J Thromb Thrombolysis2026https://conductscience.org/library/papers/42149309PubMed
42149304Platelet FcɣRIIa: a novel biomarker of risk for thromboembolism and death in cancer.J Thromb Thrombolysis2026https://conductscience.org/library/papers/42149304PubMed
41873098Thromboembolic Risks in Pancreatic Ductal Adenocarcinoma: A Review of Anatomical and Clinical Variations.Can J Gastroenterol Hepatol2026https://conductscience.org/library/papers/41873098PubMed
41643195NXTAGE: a phase 1/2 study of NXT007 to assess safety, pharmacokinetics, and efficacy in hemophilia A without inhibitors.Blood2026https://conductscience.org/library/papers/41643195PubMed
41638873Synergistic effects of anticoagulants and platelet aggregation inhibitors with immune checkpoint inhibitors in cancer therapy: a comprehensive review of preclinical and clinical evidence.J Immunother Cancer2026https://conductscience.org/library/papers/41638873PubMed
41586909Global research status and trends in venous thromboembolism and pancreatic cancer: a bibliometric analysis.Support Care Cancer2026https://conductscience.org/library/papers/41586909PubMed
41510706Circulating tumor cells and circulating tumor microemboli: role in venous thromboembolism in oncologic patients.Biosci Rep2026https://conductscience.org/library/papers/41510706PubMed
41406072Predictive Value of RDW and RCI Indices in Pulmonary Embolism: Insights from Breast Cancer, Lung Cancer, and Non-Cancer Patients.Clin Appl Thromb Hemost2025https://conductscience.org/library/papers/41406072PubMed
41249955Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial design.BMC Cancer2025https://conductscience.org/library/papers/41249955PubMed
41156207Pulmonary Embolism in Hematologic Malignancies: Predictive Value of the D-Dimer/Albumin Ratio and Proposal of the Hema-PE Score.J Clin Med2025https://conductscience.org/library/papers/41156207PubMed
40874223
Development and validation of a machine learning-based early warning system for predicting venous thromboembolism risk in hospitalized lymphoma patients undergoing chemotherapy: a multicenter and retrospective cohort study.
Front Oncol2025https://conductscience.org/library/papers/40874223PubMed
39846434Assessing the Comparative Efficacy and Safety of Warfarin and Rivaroxaban for Cancer Associated Thrombosis: Experience From a Resource Limited Setting.Cancer Rep (Hoboken)2025https://conductscience.org/library/papers/39846434PubMed
39635429Machine learning models can predict cancer-associated disseminated intravascular coagulation in critically ill colorectal cancer patients.Front Pharmacol2024https://conductscience.org/library/papers/39635429PubMed
39262796Blood cell traits and venous thromboembolism in East Asians: Observational and genetic evidence.iScience2024https://conductscience.org/library/papers/39262796PubMed
38893201Cancer-Associated Thrombosis: Pathophysiology, Laboratory Assessment, and Current Guidelines.Cancers (Basel)2024https://conductscience.org/library/papers/38893201PubMed
38676874Comprehensive evaluation of genetic and acquired thrombophilia markers for an individualized prediction of clinical thrombosis in patients with lymphoma and multiple myeloma.J Thromb Thrombolysis2024https://conductscience.org/library/papers/38676874PubMed

See all 120 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
F22147PubTator's text mininghttps://conductscience.org/library/genes/2147NCBI Gene
SELP6403PubTator's text mininghttps://conductscience.org/library/genes/6403NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23908470

GET https://conductscience.org/api/papers/v1/23908470/cited_by?page=2